ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Kikkoman Corp (PK)

Kikkoman Corp (PK) (KIKOF)

11.21
0.00
(0.00%)
마감 13 1월 6:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
11.21
매수가
9.16
매도가
11.26
거래량
-
0.00 일간 변동폭 0.00
10.55 52주 범위 13.358
market_cap
전일 종가
11.21
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
10,994
발행 주식
956,880,010
배당수익률
14,045.50%
주가수익률
0.19
주당순이익(EPS)
58.98
매출
667.7B
순이익
56.44B

Kikkoman Corp (PK) 정보

섹터
Pickld Fruit,veg,sauce,seas
산업
Food Processors Div'd
웹사이트
본부
Noda, Chiba, Jpn
설립됨
1984
Kikkoman Corp (PK) is listed in the Pickld Fruit,veg,sauce,seas sector of the OTC 시장 with ticker KIKOF. The last closing price for Kikkoman (PK) was US$11.21. Over the last year, Kikkoman (PK) shares have traded in a share price range of US$ 10.55 to US$ 13.358.

Kikkoman (PK) currently has 956,880,010 shares in issue. The market capitalisation of Kikkoman (PK) is US$10.73 billion. Kikkoman (PK) has a price to earnings ratio (PE ratio) of 0.19.

KIKOF 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
12-0.611218-5.1705162699811.82121811.82121810.551099411.68592969CS
26-0.8-6.6611157368912.0112.2510.55480711.78939099CS
52-0.89000018-7.3553732790112.1000001813.358000210.55282311.87108791CS
156-3.67744022-24.701628793514.8874402214.887440229.50583854147611.51308454CS
2601.3251598513.40598158289.8848401516.318960248.5101401392811.52640099CS

KIKOF - Frequently Asked Questions (FAQ)

What is the current Kikkoman (PK) share price?
The current share price of Kikkoman (PK) is US$ 11.21
How many Kikkoman (PK) shares are in issue?
Kikkoman (PK) has 956,880,010 shares in issue
What is the market cap of Kikkoman (PK)?
The market capitalisation of Kikkoman (PK) is USD 10.73B
What is the 1 year trading range for Kikkoman (PK) share price?
Kikkoman (PK) has traded in the range of US$ 10.55 to US$ 13.358 during the past year
What is the PE ratio of Kikkoman (PK)?
The price to earnings ratio of Kikkoman (PK) is 0.19
What is the cash to sales ratio of Kikkoman (PK)?
The cash to sales ratio of Kikkoman (PK) is 0.02
What is the reporting currency for Kikkoman (PK)?
Kikkoman (PK) reports financial results in JPY
What is the latest annual turnover for Kikkoman (PK)?
The latest annual turnover of Kikkoman (PK) is JPY 667.7B
What is the latest annual profit for Kikkoman (PK)?
The latest annual profit of Kikkoman (PK) is JPY 56.44B
What is the registered address of Kikkoman (PK)?
The registered address for Kikkoman (PK) is 250 NODA, NODA-SHI, NODA, CHIBA, 278-8601
What is the Kikkoman (PK) website address?
The website address for Kikkoman (PK) is www.kikkoman.com
Which industry sector does Kikkoman (PK) operate in?
Kikkoman (PK) operates in the FOOD PROCESSORS DIV'D sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CRGPCalissio Resources Group Inc (CE)
US$ 0.0004
(39,900.00%)
20k
NEOMNeoMedia Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
534.97k
SMMESmartMetric Inc (PK)
US$ 0.0001
(9,900.00%)
1.25M
RRGIReality Racing Inc (CE)
US$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
US$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
US$ 0.00025
(-16.67%)
129.87M
IVRT IVRT 15 분 전
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 15 분 전
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 16 분 전
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 17 분 전
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 23 분 전
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 26 분 전
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 32 분 전
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 33 분 전
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 36 분 전
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 37 분 전
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 44 분 전
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 44 분 전
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 47 분 전
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 48 분 전
He would smother any question with words.
Shawonsarker84 Shawonsarker84 50 분 전
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 52 분 전
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 56 분 전
Oh noooooo.....
FNMA
StockItOut StockItOut 57 분 전
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 1 시간 전
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 1 시간 전
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL
Louinjaxxx Louinjaxxx 1 시간 전
The reversal on Friday just reflects the entire market downturn on Friday.
AXXA
Steady_T Steady_T 1 시간 전
That sounds pretty optimistic to me. I'd think that the RA would like to see some data on other cancers before such a broad scope label.
NWBO
boi568 boi568 1 시간 전
I think he edited the question he asked to make it look neutral.
AVXL
Louinjaxxx Louinjaxxx 1 시간 전
So the extra 5 to 6 million shares will help you pay the taxes on you gain?  That makes sense.
AXXA

최근 히스토리

Delayed Upgrade Clock